Search Results

240 results for dgse

Novavax Has Growth Potential Both Now and After the Pandemic

Novavax has a Covid-19 vaccine already in production. With a world that still needs billions of doses, NVAX stock is positioned for growth.

3 Cheap Dividend Stocks For High Total Returns

Cheap dividend stocks can generate a double dose of returns, with dividends as well as capital appreciation through a rising share price.

Gilead Sciences Is a Strong Buy Despite What Its Detractors Might Say

Gilead Sciences is donating 1.5 million doses of remdesivir, which has many analysts bullish on GILD stock now.

Inovio Stock Is Still a Strong Coronavirus-Related Bet to Make

Inovio is speeding toward a vaccine for the coronavirus and has plans to make 1 million doses by the end of the year to boost…

Carnival Stock Sees A Strong Rally But Is It Worth Your Time?

CCL stock sees a strong rally after a double dose of vaccine news but investors should still proceed with caution on this investment.

Rigel Pharmaceuticals, Inc. (RIGL) Up Nearly 50% on Study Results, Price Target Increase

Rigel Pharmaceuticals, Inc. (RIGL) is flying high today after two doses of good news, as the stock strayed into overbought territory.

Why Amazon.com, Inc., Ford Motor Company and Helmerich & Payne, Inc. Are Today’s 3 Worst Stocks

Falling oil prices, disappointing earnings and a healthy dose of Wall Street skepticism sent these three big names lower Friday.

7 Cyclical Penny Stocks Best Positioned for 2024 

Cyclical penny stocks offer a double dose of upside potential for risk-seeking investors willing to take a chance for big gains.

AK Steel: The Charts Are Turning Around for AKS Stock

Tuesday’s earnings-driven rally in AKS stock appears to have given the charts of AK Steel a dose of momentum with a chance to last.

FDA Pulls Approval for a Generic Antidepressant

A generic version of antidepressant Wellbutrin has lost FDA approval after tests showed it less effective than the brand name drug at a certain dosage.

Pfizer May Have Found a New Hit Drug

The drug company’s new medication could be a game-changer. See what it treats and why one analyst thinks it’s a home run.

Novavax Stock Is a Buy Even After the Company’s Post-Dip Bounce

NVAX stock seems attractive for accumulation in the recent correction. Vaccine focus on low-income countries is likely to deliver growth.

Moderna Stock Is Worth Much More

Moderna reaps the rewards of its Covid-19 vaccine, and MRNA stock is worth 57% to 172% more based on near-term and long-term earnings power.

CureVac Is a Bet on a Safe and Effective Vaccine

CureVac is a bet on a winning Covid-19 vaccine that is effective and safe. Buying CureVac stock could produce a 27.5% annual compounded return over…

Why Is Dyne Therapeutics (DYN) Stock Up 39% Today?

Dyne Therapeutics stock is rising higher on Wednesday as investors in DYN react to positive clinical trial news from the company.

ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings

Altimmune (ALT) stock is soaring and trending after the company reported data on its GLP-1 weight-loss drug today.

The Vaccine Race Is Far From Over, And That’s Good News for Novavax

Bill Gates expects Novavax’s vaccine to be effective against Covid-19. Despite Pfizer being first, NVAX stock is still bound to benefit. 

Ocugen Just Overcame a Serious Hurdle

OCGN stock has skyrocketed on positive Phase 3 results. But the company is facing tough competition.

Wave Life Sciences News: WVE Stock Crashes 50% on Huntington’s Disease Data

Wave Life Sciences (WVE) news for Monday has WVE stock taking a beating on early data from its Huntington’s disease trial.

3 Electrical Equipment Stocks to Buy Now

This week, three electrical equipment stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall…

Novavax Stock is Set to Soar in the Year Ahead

The potential rewards in NVAX stock far outweigh the risks as the vaccine maker awaits regulatory approval from the WHO and others.

Moderna Is Ready To Rally After 2-Month Market Correction

MRNA stock is ready to rally once again, as the company gears up to deliver millions of Covid-19 vaccines in 2021 and help end this…

Covid-19 Vaccine Orders Are Piling Up, Moderna Stock Has Room to Grow

With production ramping to 1.4 billion doses and next-gen vaccine in trials, don’t underestimate Covid-19 vaccine upside for MRNA stock.

Why Is GSE Systems (GVP) Stock Up 59% Today?

GSE Systems shares are rocketing higher on Friday despite a lack of news. However, GVP stock is seeing incredibly heavy trading this morning!

3 – 10 of 240 results